Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects
Not Applicable
Recruiting
- Conditions
- Bipolar DisorderMajor Depressive Disorder
- Interventions
- Diagnostic Test: EDIT-B test (without giving result)Diagnostic Test: EDIT-B test
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Alcediag
- Target Recruit Count
- 450
- Registration Number
- NCT06507787
- Locations
- 🇫🇷
CH Erstein, Erstein, France
🇫🇷AP-HP Corentin Celton, Issy-les-Moulineaux, France
🇫🇷Etablissement Public de Santé Mentale (EPSM) 74, La Roche-sur-Foron, France
Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers
Completed
- Conditions
- Major Depressive DisorderBipolar Disorder
- Interventions
- Device: EDIT-B
- First Posted Date
- 2022-11-03
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Alcediag
- Target Recruit Count
- 418
- Registration Number
- NCT05603819
- Locations
- 🇩🇰
The Capital Region of Denmark, Copenhagen, Denmark
🇫🇷GHU Paris Psychiatrie & Neurosciences, Paris, France
🇪🇸Parc Sanitari Sant Joan de Déu, Sant Boi De Llobregat, Barcelona, Spain
© Copyright 2025. All Rights Reserved by MedPath